You are here

Article Text

Article menu
Download PDFPDF
Prognosis
Cohort study
Cardiovascular risks of stopping antiplatelet therapy before non-cardiac surgery for patients with coronary stents
  1. Thomas M Maddox
  1. Department of Cardiology, VA Eastern Colorado Health Care System/University of Colorado Denver, Colorado, USA
  1. Correspondence to Thomas M Maddox
    Department of Cardiology, VA Eastern Colorado Health Care System/University of Colorado Denver, 1055 Clermont Street, Denver, CO 80210, USA; thomas.maddox{at}va.gov

https://doi.org/10.1136/ebmed.2011.100381

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Albaladejo P, Marret E, Samama CM, et al. Non-cardiac surgery in patients with coronary stents: the RECO study. Heart 2011;97:1566–72.OpenUrlAbstract/FREE Full Text

    Context

    The use of stents in percutaneous coronary intervention (PCI) increases procedural success and decreases restenosis, but it complicates subsequent surgical procedures in these patients.1 Between 5% and 15% of PCI patients undergo non-cardiac surgery in the year following PCI, and are at high risk of experiencing cardiovascular (CV) complications.2 The most serious risk is stent thrombosis, which occurs in 2.5% of patients and is fatal in 40%.3 Although guidelines for the management of these patients are available, the evidence supporting them is lacking.4 Key questions remain regarding contemporary …

    View Full Text

    Footnotes

    • Competing interests None.